Belmont, CA, United States of America

Maarten Hoek

This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Maze Therapeutics, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maarten Hoek. Retrieved from https://idiyas.com/inventor/maarten-hoek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Maarten Hoek

Introduction

Maarten Hoek is a notable inventor based in Belmont, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 2 patents to his name, his work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents are the APOL1 inhibitors and methods of use. These patents detail compounds of formula (II) and their applications in inhibiting APOL1, which is crucial for treating APOL1-mediated diseases, disorders, or conditions. The patents also include methods for preparing these compounds and their pharmaceutically acceptable salts.

Career Highlights

Maarten Hoek is currently associated with Maze Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing therapies that can significantly improve patient outcomes.

Collaborations

He collaborates with talented individuals such as Patrick Sang Tae Lee and Todd Jonathan August Ewing, contributing to a dynamic research environment that fosters innovation.

Conclusion

Maarten Hoek's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work on APOL1 inhibitors is particularly promising for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…